Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR7748ApriorityCriticalpatent/CR7748A/en
Publication of CR7748ApublicationCriticalpatent/CR7748A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen nuevos compuestos de pirazol, incluyendo sus derivados, intermedios para su preparacion, composiciones farmaceuticas que contienen y su uso medicinal. Los compuestos de la presente invencion son inhibidores potentes de la ruta se senalizacion del factor del crecimiento trasformante ("TGF)-B. Son de utilidad en el tratamiento de diversos estados de enfermedad relacionados con TGF incluyendo, por ejemplo cancer y enfermedades fibroticas.New pyrazole compounds are described, including their derivatives, intermediates for their preparation, pharmaceutical compositions containing and their medicinal use. The compounds of the present invention are potent inhibitors of the signaling pathway of the transforming growth factor ("TGF) -B. They are useful in the treatment of various disease states related to TGF including, for example cancer and fibrotic diseases.
CR7748A2005-03-162005-03-16
NEW PIRAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
CR7748A
(en)
GROUP OF BENZOIL-AMINO-HETEROCICLILO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, USEFUL FOR TREATMENT OF GLUCOQUINASE-AIDED DISEASES (GQ)
DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS.